Frankfurt - Delayed Quote EUR
Aptose Biosciences Inc. R (LTI0.F)
2.0200
+0.0200
+(1.00%)
At close: 8:00:46 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
26,257
26,257
52,356
42,602
65,447
Operating Income
-26,257
-26,257
-52,356
-42,602
-65,447
Net Non Operating Interest Income Expense
150
150
1,151
788
94
Other Income Expense
677
677
-2
-9
-1
Pretax Income
-25,430
-25,430
-51,207
-41,823
-65,354
Net Income Common Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Diluted NI Available to Com Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Basic EPS
-87.60
-36.38
-227.43
-204.00
-328.50
Diluted EPS
-87.60
-36.38
-227.43
-204.00
-328.50
Basic Average Shares
468.0660
698.9790
225.1540
205.0330
197.9680
Diluted Average Shares
468.0660
698.9790
225.1540
205.0330
197.9680
Total Expenses
26,257
26,257
52,356
42,602
65,447
Net Income from Continuing & Discontinued Operation
-25,430
-25,430
-51,207
-41,823
-65,354
Normalized Income
-26,107
-26,107
-51,205
-41,814
-65,353
Interest Income
357
357
1,151
788
94
Interest Expense
207
207
--
--
--
Net Interest Income
150
150
1,151
788
94
EBIT
-25,223
-25,223
-51,207
-42,602
-65,447
EBITDA
-24,819
-24,819
-50,741
-42,074
-64,825
Reconciled Depreciation
404
404
466
528
622
Net Income from Continuing Operation Net Minority Interest
-25,430
-25,430
-51,207
-41,823
-65,354
Total Unusual Items Excluding Goodwill
677
677
-2
-9
-1
Total Unusual Items
677
677
-2
-9
-1
Normalized EBITDA
-25,496
-25,496
-50,739
-42,065
-64,824
12/31/2021 - 1/20/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLVLY Clinuvel Pharmaceuticals Limited
7.10
0.00%
BINV.ST BioInvent International AB (publ)
29.10
+3.19%
WHWK Whitehawk Therapeutics, Inc.
1.5400
0.00%
EXOZ eXoZymes, Inc.
13.53
+14.76%
NEUP Neuphoria Therapeutics Inc.
5.11
+1.19%
SANION.ST Saniona AB (publ)
7.21
+7.61%
THAR Tharimmune, Inc.
1.2052
+3.90%
ABVX ABIVAX Société Anonyme
6.77
+4.08%
TYRA Tyra Biosciences, Inc.
10.02
+5.81%
VIRX Viracta Therapeutics, Inc.
0.0173
+1.76%